Not independent
Tenure on this board
5.0 yrs
Meeting calendar
DOCS · Annual meeting · Thursday, August 28, 2025
Doximity Inc
2 nominees · 3 ballot items.
Election of two Class I directors; ratification of Deloitte & Touche LLP as independent registered public accounting firm for the year ending March 31, 2026; advisory Say-on-Pay vote on compensation of our named executive officers.
Market cap
$3.9B
1Y TSR
-63.8%
Board grade
C-
Record date
Jul 3, 2025
Filing
DEF 14A
Meeting concluded · Aug 28, 2025
Follow how the vote landed and what changed on Doximity Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of two Class I directors
ManagementBoard: FORElection of two Class I directors to hold office until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified, subject to their earlier resignation or removal.
- 2
Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending March 31, 2026
ManagementBoard: FOROur audit committee has appointed Deloitte & Touche LLP as our independent registered public accounting firm to perform the audit of our consolidated financial statements for the year ending March 31, 2026, and stockholders are asked to ratify this appointment.
- 3
Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers
ManagementBoard: FORNon-binding advisory vote to approve the compensation of our named executive officers for the fiscal year ended March 31, 2025, as disclosed in this Proxy Statement.
Director elections
Nominees on the ballot2
Independent
Tenure on this board
5.0 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.5% | 8,262,475 | $193M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.5% | 6,394,107 | $149M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.2% | 5,765,063 | $134M |
| 4 | Clearbridge Investments, LLC | 2.7% | 4,975,398 | $116M |
| 5 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.6% | 4,834,220 | $113M |
| 6 | Carmignac Gestion | 2.4% | 4,311,997 | $100M |
| 7 | BlackRock, Inc. | 2.2% | 4,099,735 | $96M |
| 8 | STATE STREET CORP | 2.2% | 4,039,510 | $94M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 3,448,788 | $80M |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 1.7% | 3,059,749 | $71M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Doximity Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Catalyst Pharmaceuticals IncCPRX
Special meeting·Jul 8, 2026·$3.8B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.6B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.4B
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.5B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.2B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$2.0B
Reference
Frequently asked questions
- When is the Doximity Inc 2025 annual meeting?
- Doximity Inc (DOCS) holds its 2025 annual shareholder meeting on Thursday, August 28, 2025.
- What is the record date for the Doximity Inc 2025 meeting?
- The record date for the Doximity Inc 2025 meeting is Thursday, July 3, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Doximity Inc's 2025 meeting?
- The board is presenting 2 director nominees at the Doximity Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Doximity Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Doximity Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.